A consortium made up of several European universities and an Ontario-based biotech company reported they have achieved several breakthroughs in their work on a regenerative medicine therapy to treat Hemophilia A. Continue ReadingRead More »
Approximately 10 million people worldwide are believed to be suffering from dementia brought about by human immunodeficiency virus (HIV). Now, a team of researchers from the University of Alberta believes that have arrived at “strong clues” to the underlying cause of HIV-associated neurocognitive disorder or HAND. Continue ReadingRead More »
Ontario’ gateway to the cancer research pipeline has launched a cross-border campaign aimed at people with strong clinical development, commercial and fundraising experience in the technology and life sciences sectors.
Fight Against Cancer Innovation Trust’s (FACIT) recruitment drive comes at a time when changes in the American political scene appears to be impacting that country’s scientific environment.Read More »
Using the gene editor CRISPR, Harvard scientists were able to save videos in DNA. In a study published in Nature, the team at the Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) led by Wyss core faculty member George Church explained that the CRISPR system can encode information, such a digitized image, in living cells. Continue ReadingRead More »
From September 11th to the 12th this year, Vantage Bio trials will be holding its 2nd annual Canada Talks Pharma conference. The event is an opportunity for professionals in the biotechnology and pharmaceutical industries to get together, exchange views, and learn about innovative ideas, new technologies, and clinical research methods. Continue ReadingRead More »
At least one hundred million people in developing countries have contracted hepatitis C. Early detection is key to providing timely treatment for the deadly blood-borne liver infection, however, testing tools are often in low supply and expensive in many regions.
Researchers at the University of Toronto are developing a disposable “dipstick” type diagnostic tool which works like a home pregnancy test. The tool could one day help health workers around the world detect hepatitis C. Continue ReadingRead More »